Educational Activities

Certified Activity
Non-certified Activity
Resource
Patient Education
Expired Activity

1-6 of 120 Activities

Title
Availability
Format
Credits
Launch Date
Buttons
Buttons
On-Demand
Podcast
0.5
02/28/2024

Up for Debate: Effective First-line Maintenance Strategies for Advanced Ovarian Cancer

Recent data has led to a debate of the most effective maintenance strategy for advanced OC. Emerging data utilizing novel approaches to maintenance both further complicates the debate and sheds new light on novel effective strategies for maintenance therapy for advanced OC, leaving clinicians struggling to adopt appropriate strategies.  In order to ensure that clinical decisions align with the latest emerging data regarding maintenance therapy in OC, Drs. Richard Penson and Kathleen Moore will educate clinicians on the role of biomarkers in OC, incorporation of genetic testing, and interpretation of results as part of clinical practice.

0.5
02/28/2024

Kathleen N. Moore, MD

Kathleen N. Moore, MD

Richard T. Penson

Richard T. Penson, MD, MRCP, is a Medical Oncologist at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. A key opinion leader, Dr. Penson was a longstanding member of the Gynecologic Oncology Group Ovarian and Quality of Life Committees and now serves on the Foundation’s Investigator Council.

Richard T. Penson

(Moderator)

Richard T. Penson, MD, MRCP, is a Medical Oncologist at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School. A key opinion leader, Dr. Penson was a longstanding member of the Gynecologic Oncology Group Ovarian and Quality of Life Committees and now serves on the Foundation’s Investigator Council. He is the national Principal Investigator (PI) of the olaparib registration trial (SOLO-2) and the international PI of SOLO3, and the OVAL trial. He has taught on Harvard’s Practice of Medicine Course, the Bigelow General Medical Service at Massachusetts General Hospital, and is one of the Chairs of the Institutional Review Board of Dana-Farber Harvard Cancer Center.

Buttons
On-Demand
CME Commentary
1
02/28/2024

Clinical Pathways in T2D Care: Overcoming Inertia, Implementing Innovation

This CMEO digital monograph serves to highlight the presentations of a 2-day educational activity, moderated by Timothy Garvey, MD, which focused on co-occurrence of obesity with elevated A1C and other cardiometabolic risk factors, applications of incretin therapy, and intensification strategies and therapies in the management of T2D.

1
02/28/2024

W. Timothy Garvey, MD

W. Timothy Garvey, MD

Buttons
On-Demand
Webinar
1.5
02/01/2024

Clean-Up on IL-23: Integrating the Science of Inflammatory Targets into Treatment Decision-making in IBD

This CME Outfitters Webcast, entitled Clean-Up on IL-23: Integrating the Science of Inflammatory Targets into Treatment Decision-making in IBD, will feature an expert panel discussion on the science behind cytokine-targeting therapies and will utilize animated 3-D models to discuss therapeutic mechanisms of action (MOAs) of emerging agents, clinical distinctions between therapies, and individualizing treatments for lasting outcomes for patients with IBD.

1.5
02/01/2024

Maria T. Abreu

Maria T. Abreu, MD is a Gastroenterologist who specializes in inflammatory bowel disease (IBD). She completed her medical degree at the University of Miami, Miller School of Medicine. Her postdoctoral training included an internship and residency in medicine at the Brigham and Women’s Hospital in Boston, Massachusetts, and a clinical and research fellowship in gastroenterology at the University of California, Los Angeles (UCLA).

Maria T. Abreu

Maria T. Abreu, MD is a Gastroenterologist who specializes in inflammatory bowel disease (IBD). She completed her medical degree at the University of Miami, Miller School of Medicine. Her postdoctoral training included an internship and residency in medicine at the Brigham and Women’s Hospital in Boston, Massachusetts, and a clinical and research fellowship in gastroenterology at the University of California, Los Angeles (UCLA). Dr. Abreu is the Director of the Crohn’s and Colitis Center, Professor of Medicine, and Professor of Microbiology and Immunology at the University of Miami Miller School of Medicine in Miami, Florida.

Dr. Abreu has more than 20 years of leadership experience in basic, translational, and clinical research and mentoring. She was elected to the American Society for Clinical Investigation in 2010 and, in 2018, to the Association of American Physicians (AAP). She completed a three-year term as Chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) in 2022. In 2019, she was elected Councilor-at-Large of the American Gastroenterological Association (AGA) Governing Board for a term of three years. Most recently, she is President-Elect of the AGA, on the path to becoming President in 2024. She will be the fifth woman and first Latina to hold this position.

Dr. Abreu is a recipient of the 2019 Sherman Prize by The Bruce and Cynthia Sherman Charitable Foundation, which recognizes outstanding achievements in IBD. In 2020, she received the Mentoring Award from the Immunology, Microbiology, and Inflammatory Bowel Diseases (IMIBD) section of the AGA. In the Fall of 2020, she received the Healio’s Lifetime Disruptor Award. This award goes to a gastroenterologist or hepatologist who consistently pushed the gastroenterology field forward through innovative treatments, practice management, patient care, or research. She is the 30th alumnus inducted into the University of Miami Miller School of Medicine Hall of Fame. Dr. Abreu is frequently invited as a speaker (in English and Spanish) at symposia on basic science and clinical topics all over the world. She has authored more than 200 peer-reviewed articles, books, chapters, and reviews.

Jessica R. Allegretti, MD, MPH, FACG, AGAF

Jessica R. Allegretti, MD, MPH, FACG, AGAF

David T. Rubin

David T. Rubin, MD, FACG, AGAF, FACP, FASGE, FRCP (Edinburgh) is the Joseph B. Kirsner Professor of Medicine, a Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology and Nutrition, and Director of the Inflammatory Bowel Disease (IBD) Center at the University of Chicago Medicine in Chicago, Illinois.

David T. Rubin

David T. Rubin, MD, FACG, AGAF, FACP, FASGE, FRCP (Edinburgh) is the Joseph B. Kirsner Professor of Medicine, a Professor of Pathology, Chief of the Section of Gastroenterology, Hepatology and Nutrition, and Director of the Inflammatory Bowel Disease (IBD) Center at the University of Chicago Medicine in Chicago, Illinois. Dr. Rubin earned a medical degree with honors at the University of Chicago Pritzker School of Medicine in Chicago, Illinois and completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago in Chicago, Illinois, where he served as Chief Resident and Chief Fellow. He also serves as Associate Faculty at the MacLean Center for Clinical Medical Ethics, Associate Investigator at the University of Chicago Comprehensive Cancer Center, and is a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics. He is the chair of the National Scientific Advisory Committee of the Crohn’s & Colitis Foundation, where he also serves as a Board of Trustees member. Dr. Rubin is the deputy chair of the Executive Committee of the International Organization for the Study of Inflammatory Bowel Disease. Prior to these appointments, he served as the Director of the Fellowship in Gastroenterology, Hepatology and Nutrition at the University of Chicago for 11 years. In 2018, Dr. Rubin completed the Harvard T.H. Chan School of Public Health Leadership Development Course for Physicians.

Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE), the American College of Physicians (ACP), and the Royal College of Physicians (Edinburgh). He is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), and the UChicago Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the Crohn’s & Colitis Foundation’s Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He has previously served as an Associate Editor of the journal Gastroenterology and Editor-in-Chief of the ACG On-Line Education Universe. In 2020, Dr. Rubin received the Sherman Prize for Excellence in Crohn’s and Colitis.

Dr. Rubin is an editor of a best-selling book Curbside Consultation in IBD, now in its 3rd edition, was an associate editor of the 11th edition and is senior editor of the upcoming 12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, and an author or coauthor of over 500 articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the 2019 ACG Guidelines for ulcerative colitis. His current research is in the area of novel approaches to monitoring of IBD (wearables and point of care intestinal ultrasound), prevention of progressive complications from uncontrolled inflammation, and a variety of collaborative and translational studies related to the causes of IBD and its complications. His H index is 74. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular and verified twitter feed @IBDMD with over 20,000 followers.

Buttons
On-Demand
Briefcase
0.5
01/10/2024

ARIA Alert: Timely Recognition in the Emergency Department

The first episode of this CMEO BriefCase series focuses on a patient case that requires differentiating ARIA from other conditions with a similar presentation in the emergency care setting, highlighting ARIA-related symptoms, listing other clinical manifestations of ARIA as described in clinical trials, and reviewing contraindicated medications for patients receiving an ATT.

0.5
01/10/2024

Ana M. Franceschi, MD, PhD

Ana M. Franceschi, MD, PhD

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris.

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris. He trained as an MD and a clinical fellow in Paris in Prof. Bruno Dubois’ group and carried out his PhD with Dr. Gaël Chételat in Caen, France, where he worked on multimodal neuroimaging and disconnection mechanisms in Alzheimer’s disease. He currently leads projects on brain network vulnerability using multimodal neuroimaging and on fluid biomarkers of Alzheimer’s disease in Prof. Kaj Blennow’s new group at the Paris Brain Institute.

Buttons
On-Demand
Briefcase
0.5
12/21/2023

How to Treat ARIA in Emergency Settings: Timely Communication with Multi-Disciplinary Colleagues

The third and final episode of this CMEO BriefCase series focuses on a case involving a patient on an ATT presenting to the emergency department (ED), highlighting ED protocols to streamline care for patients with severe ARIA, recommendations for treatment and supportive care measures, global resources for guidance as the ATT landscape expands, management of ARIA according to best guidance, and communication with ATT-treating clinicians and radiologists.

0.5
12/21/2023

Karen Greenberg

Karen Greenberg, DO, FACOEP-D, FAAEM, FAHA is double board certified in emergency medicine and neurocritical care and highly specialized in the treatment of neurological emergencies.

Karen Greenberg

Karen Greenberg, DO, FACOEP-D, FAAEM, FAHA is double board certified in emergency medicine and neurocritical care and highly specialized in the treatment of neurological emergencies.

Dr. Greenberg’s work was critical to the establishment of the nation’s first dedicated Neurologic Emergency Department. The American College of Osteopathic Emergency Physicians (ACOEP) recognized her innovations to speed critical treatment to patients experiencing acute ischemic stroke and awarded her its inaugural Practice Innovation Award. In 2021 Dr. Greenberg received the Willoughby Award from the ACOEP that honors the top female leader in emergency medicine.

Dr Greenberg has numerous publications in emergency, neurology, and neurosurgery journals and has authored book chapters as well. She has been honored with distinguished fellowship of the American College of Osteopathic Emergency Physicians, and is a fellow of the American Academy of Emergency Medicine and American Heart Association as well. She is an assistant professor of neurosurgery, neurology, and emergency medicine with Drexel University College of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia College of Osteopathic Medicine, and Rowan School of Osteopathic Medicine.

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris.

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris. He trained as an MD and a clinical fellow in Paris in Prof. Bruno Dubois’ group and carried out his PhD with Dr. Gaël Chételat in Caen, France, where he worked on multimodal neuroimaging and disconnection mechanisms in Alzheimer’s disease. He currently leads projects on brain network vulnerability using multimodal neuroimaging and on fluid biomarkers of Alzheimer’s disease in Prof. Kaj Blennow’s new group at the Paris Brain Institute.

Buttons
On-Demand
Briefcase
0.5
12/20/2023

What to Do: My Patient in the ED May Have ARIA

The second episode of this CMEO BriefCase series focuses on a patient case that demonstrates real-world challenges such as obtainment of an accurate medical history, imaging needs and interpretations, and what to do if magnetic resonance imaging (MRI) is not accessible.

0.5
12/20/2023

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris.

Nicolas Villain

Nicolas Villain, MD, PhD, is a tenured Associate Professor of Neurology at Sorbonne University, Paris, France and a cognitive and behavioral neurologist at the Institute of Memory and Alzheimer’s Disease, Department of Neurology, Pitié-Salpêtrière Hospital, Paris. He trained as an MD and a clinical fellow in Paris in Prof. Bruno Dubois’ group and carried out his PhD with Dr. Gaël Chételat in Caen, France, where he worked on multimodal neuroimaging and disconnection mechanisms in Alzheimer’s disease. He currently leads projects on brain network vulnerability using multimodal neuroimaging and on fluid biomarkers of Alzheimer’s disease in Prof. Kaj Blennow’s new group at the Paris Brain Institute.

Jimmy L. Pruitt III

Jimmy L. Pruitt III, PharmD, BCPS, BCCCP, BCEMP, is originally from Orlando, Florida, and received his Doctor of Pharmacy from Presbyterian College School of Pharmacy in 2017.

Jimmy L. Pruitt III

Jimmy L. Pruitt III, PharmD, BCPS, BCCCP, BCEMP, is originally from Orlando, Florida, and received his Doctor of Pharmacy from Presbyterian College School of Pharmacy in 2017. He completed a PGY-1 pharmacy residency at Florida Hospital Orlando and then went on to Grady Health System in Atlanta, Georgia, for his PGY2 emergency medicine residency. Dr. Pruitt is currently an emergency medicine clinical pharmacy specialist at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He was awarded Grady Pharmacist of the Year in 2019 as a PGY2 emergency medicine resident, which was a first in the program’s 30+ year history. In 2020, he obtained Board-Certified Pharmacotherapy Specialist (BCPS) and Board-Certified Critical Care Pharmacist (BCCCP) recognition. Also, in 2020, he won the Society of Academic Emergency Medicine (SAEM) Got Talent competition for his educational series “Pharmacy Friday Pearls,” which was the first time a pharmacist won the event. In 2021, Dr. Pruitt was honored with the Excellence in Diversity award from MUSC College of Pharmacy, was Presbyterian College School of Pharmacy (PCSP) Alumni of the Year, and was keynote speaker for the 2021 PCPS graduation. His professional interests include cardiac arrest, shock syndromes, trauma, and hosting his podcast Pharm So Hard. Dr. Pruitt obtained board certification in emergency medicine in May 2023.